» Articles » PMID: 31129737

Bronchial Arterial Embolization Using a Gelatin Sponge for Hemoptysis from Pulmonary Aspergilloma: Comparison with Other Pulmonary Diseases

Overview
Journal Emerg Radiol
Date 2019 May 27
PMID 31129737
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the clinical outcomes of bronchial artery embolization (BAE) using a gelatin sponge for hemoptysis from pulmonary aspergilloma and compare them with treatment outcomes for hemoptysis from other diseases.

Methods: Fifty-two patients underwent BAE using a gelatin sponge. The etiology of hemoptysis was pulmonary aspergilloma in 8 (PA group) and other diseases in 44 (control group). The technical success rate, clinical success rate, hemoptysis-free rate, and complication rate were compared between the PA group and control group. Technical success was defined as the complete cessation of the targeted feeding artery as confirmed by digital subtraction angiography, and clinical success as the cessation of hemoptysis within 24 h of BAE. Recurrent hemoptysis was defined as a single or multiple episodes of hemoptysis causing > 30 ml of bleeding per day.

Results: Technical and clinical success rates were 100% in both groups. Hemoptysis-free rates were 85% at 6 months and 72% at 12-60 months in the control group, and 38% at 6-12 months and 25% thereafter in the PA group (P = 0.0009). No complications were observed following BAE in any case in the two groups.

Conclusion: BAE using a gelatin sponge may not be effective for hemoptysis from pulmonary aspergilloma.

Citing Articles

The efficacy, safety, and related factors of bronchial artery embolization for hemoptysis: a systematic review and meta-analysis with subgroup analysis.

Tao Y, Li J, Su R, Zhou M, Zhu H, Sun Z Cardiovasc Diagn Ther. 2024; 14(5):859-877.

PMID: 39513143 PMC: 11538829. DOI: 10.21037/cdt-24-157.


Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challenges.

Tashiro M, Takazono T, Izumikawa K Ther Adv Infect Dis. 2024; 11:20499361241253751.

PMID: 38899061 PMC: 11186400. DOI: 10.1177/20499361241253751.


The effectiveness of the puncture channel plugging for reduction of complications after CT-guided percutaneous transthoracic needle biopsy.

Wang D, Wang Y, Ding G, Li B, Liu R, Ai Z Sci Rep. 2023; 13(1):12318.

PMID: 37516777 PMC: 10387056. DOI: 10.1038/s41598-023-38915-y.


Bronchial Artery Embolization.

Kaufman C, Kwan S Semin Intervent Radiol. 2022; 39(3):210-217.

PMID: 36062235 PMC: 9433160. DOI: 10.1055/s-0042-1751293.


Bronchial artery embolization for hemoptysis: A systematic review and meta-analysis.

Zheng Z, Zhuang Z, Yang M, Luo J, Zhang W, Yan Z J Interv Med. 2022; 4(4):172-180.

PMID: 35586385 PMC: 8947981. DOI: 10.1016/j.jimed.2021.08.003.


References
1.
Chun J, Morgan R, Belli A . Radiological management of hemoptysis: a comprehensive review of diagnostic imaging and bronchial arterial embolization. Cardiovasc Intervent Radiol. 2010; 33(2):240-50. DOI: 10.1007/s00270-009-9788-z. View

2.
Ding W, Chan T, Yadavilli R, McWilliams R . Aspergilloma and massive haemoptysis. BMJ Case Rep. 2014; 2014. PMC: 3992544. DOI: 10.1136/bcr-2013-200019. View

3.
Soubani A, Chandrasekar P . The clinical spectrum of pulmonary aspergillosis. Chest. 2002; 121(6):1988-99. DOI: 10.1378/chest.121.6.1988. View

4.
White Jr R . Bronchial artery embolotherapy for control of acute hemoptysis: analysis of outcome. Chest. 1999; 115(4):912-5. DOI: 10.1378/chest.115.4.912. View

5.
Yoon W, Kim J, Kim Y, Chung T, Kang H . Bronchial and nonbronchial systemic artery embolization for life-threatening hemoptysis: a comprehensive review. Radiographics. 2002; 22(6):1395-409. DOI: 10.1148/rg.226015180. View